Tove Kirkegaard
Tove Kirkegaard
Kirurgisk Afdeling, Køge og Roskilde Sygehus, Forskningskoordinator
Bekræftet mail på tovekirkegaard.dk
Titel
Citeret af
Citeret af
År
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
T Kirkegaard, CJ Witton, LM McGlynn, SM Tovey, B Dunne, A Lyon, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005
3022005
Plasminogen activator inhibitor-1 represses integrin-and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
L Kjøller, SM Kanse, T Kirkegaard, KW Rodenburg, E Rønne, ...
Experimental cell research 232 (2), 420-429, 1997
2731997
Proteinases in bone resorption: obvious and less obvious roles
JM Delaissé, MT Engsig, V Everts, M del Carmen Ovejero, M Ferreras, ...
Clinica Chimica Acta 291 (2), 223-234, 2000
2422000
Observer variation in immunohistochemical analysis of protein expression, time for a change?
T Kirkegaard, J Edwards, S Tovey, LM McGlynn, SN Krishna, ...
Histopathology 48 (7), 787-794, 2006
2152006
Tumour necrosis factor α converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease
J Brynskov, P Foegh, G Pedersen, C Ellervik, T Kirkegaard, A Bingham, ...
Gut 51 (1), 37-43, 2002
1972002
Tumour necrosis factor α converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease
J Brynskov, P Foegh, G Pedersen, C Ellervik, T Kirkegaard, A Bingham, ...
Gut 51 (1), 37-43, 2002
1972002
Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn’s disease
T Kirkegaard, A Hansen, E Bruun, J Brynskov
Gut 53 (5), 701-709, 2004
1842004
Transforming growth factor-β controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression
MA Karsdal, P Hjorth, K Henriksen, T Kirkegaard, KL Nielsen, H Lou, ...
Journal of Biological Chemistry 278 (45), 44975-44987, 2003
1612003
A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells
TL Andersen, M del Carmen Ovejero, T Kirkegaard, T Lenhard, NT Foged, ...
Bone 35 (5), 1107-1119, 2004
1422004
Amplified in breast cancer 1 in human epidermal growth factor receptor–positive tumors of tamoxifen-treated breast cancer patients
T Kirkegaard, LM McGlynn, FM Campbell, S Müller, SM Tovey, B Dunne, ...
Clinical Cancer Research 13 (5), 1405-1411, 2007
1362007
Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on the involvement of MMPs in bone resorption
P Hou, T Troen, MC Ovejero, T Kirkegaard, TL Andersen, I Byrjalsen, ...
Bone 34 (1), 37-47, 2004
1102004
Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients
LM McGlynn, T Kirkegaard, J Edwards, S Tovey, D Cameron, C Twelves, ...
Clinical cancer research 15 (4), 1487-1495, 2009
862009
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
PJ Devereaux, E Duceppe, G Guyatt, V Tandon, R Rodseth, BM Biccard, ...
The Lancet 391 (10137), 2325-2334, 2018
712018
Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH
T Kirkegaard, CJ Witton, J Edwards, KV Nielsen, LB Jensen, ...
Histopathology 56 (2), 203-211, 2010
622010
Kinetic analysis of integrin‐dependent cell adhesion on vitronectin: The inhibitory potential of plasminogen activator inhibitor‐1 and RGD peptides
M Germer, SM Kanse, T Kirkegaard, L Kjøller, B Felding‐Habermann, ...
European journal of biochemistry 253 (3), 669-674, 1998
591998
Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium
G Pedersen, T Saermark, T Kirkegaard, J Brynskov
Clinical & Experimental Immunology 155 (2), 257-265, 2009
512009
Bad expression predicts outcome in patients treated with tamoxifen
E Cannings, T Kirkegaard, SM Tovey, B Dunne, TG Cooke, JMS Bartlett
Breast cancer research and treatment 102 (2), 173-179, 2007
502007
High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer
CL Alves, D Elias, M Lyng, M Bak, T Kirkegaard, AE Lykkesfeldt, HJ Ditzel
Clinical cancer research 22 (22), 5514-5526, 2016
382016
A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells
S Thrane, AM Pedersen, MBH Thomsen, T Kirkegaard, BB Rasmussen, ...
Oncogene 34 (32), 4199-4210, 2015
382015
Genetic alterations of CCND1 and EMSY in breast cancers
T Kirkegaard, KV Nielsen, LB Jensen, FM Campbell, S Müller, SM Tovey, ...
Histopathology 52 (6), 698-705, 2008
382008
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20